Zobrazeno 1 - 10
of 107
pro vyhledávání: '"I. Peyrottes"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Claire Chapellier, Philippe Follana, C. Cavrot, Emmanuel Barranger, J. Antomarchi, I. Peyrottes, J-M Ferrero, T. Ihrai, Emmanuel Chamorey, B. Flipo
Publikováno v:
Clinical Breast Cancer. 15:e231-e235
Aim: The aim of this study was to determine the rate of breast -onserving surgery (BCS) after neoadjuvant chemotherapy (nCT) in patients initially thought suitable for mastectomy as the only conceivable surgical option. Methods: This retrospective st
Publikováno v:
Cancer/Radiothérapie. 23:794
Introduction et but de l’etude L’irradiation partielle et acceleree du sein par une technique de curietherapie de haut debit de dose est validee pour les cancers du sein a faible risque. Chez les patientes âgees, les criteres de selections reste
Autor:
P. Agoston, A. Lecesne, B.A. Perez, S. Carrere, Philippe Rochaix, Z. Sapi, M.C. Chateau, Marie-Pierre Sunyach, Zsuzsanna Papai, M. Laé, I. Peyrottes, N. Fernando, C. Llacer, Juliette Thariat, Colette J. Shen, S. Bonvalot, H. Brisse, Tanguy Y. Seiwert, Anne Ducassou
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 105:E651-E652
Autor:
T. Tornoczky, M. Laé, Martine Delannes, J. Galon, I. Peyrottes, A. Lecesne, Z. Sapi, S. Bonvalot, Péter Ágoston, Philippe Rochaix, M.C. Château, Marie-Pierre Sunyach, R. Tetreau, H. Brisse, Paul Sargos, S. Carrere, Zsusanna Papai, C. Llacer, Juliette Thariat, László Mangel
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:S204-S205
Autor:
M, Lupu-Plesu, A, Claren, S, Martial, P-D, N'Diaye, K, Lebrigand, N, Pons, D, Ambrosetti, I, Peyrottes, J, Feuillade, J, Hérault, M, Dufies, J, Doyen, G, Pagès
Publikováno v:
Oncogenesis
The proximity of organs at risk makes the treatment of head and neck squamous cell carcinoma (HNSCC) challenging by standard radiotherapy. The higher precision in tumor targeting of proton (P) therapy could promote it as the treatment of choice for H
Autor:
Mathieu Gautier, Marie-Eve Chand, J. Lévy, D. Lam Cham Kee, Jean-Michel Hannoun-Levi, S. Sumodhee, I. Peyrottes, M. Kogay, E. Chamorey, E. Barranger
Publikováno v:
Cancer/Radiothérapie. 21:699-700
Objectif de l’etude L’objectif de l’etude etait, comparer la probabilite de survie sans mastectomie a 10 ans observee apres irradiation partielle et acceleree a celles estimees avec et sans irradiation totale du sein, chez les patientes âgees
Autor:
Alexandre Bozec, F. Demard, Anne Sudaka, Emmanuel Chamorey, E.-E.-M. Nao, J.-C. Riss, Gilles Poissonnet, Olivier Dassonville, P.-Y. Marcy, Jacques Vallicioni, J. Santini, I. Peyrottes, D. Benisvy, Juliette Haudebourg
Publikováno v:
Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale. 129:208-212
Resume Objectif Le but de notre etude est d’evaluer l’impact pronostique de la multifocalite tumorale dans le cadre des microcarcinomes papillaires (MCP) de la glande thyroide. Methodes Nous avons mene une etude retrospective portant sur l’ense
Autor:
C. Trastour, Jacques Pouysségur, F. Ettore, J-M Ferrero, N. Toussant, J. Gal, I. Peyrottes, Danièle Roux, Karine Ilc, Jérôme Doyen, Scott K. Parks
Publikováno v:
Biochemical and Biophysical Research Communications; Vol 451
Biochemical and Biophysical Research Communications
Biochemical and Biophysical Research Communications
Background 18 Fluor-deoxy-glucose PET-scanning of glycolytic metabolism is being used for staging in many tumors however its impact on prognosis has never been studied in breast cancer. Methods Glycolytic and hypoxic markers: glucose transporter (GLU
Autor:
P Rostagno, Moïse Namer, Jean-Marc Ferrero, F. Ettore, P. Leblanc-Talent, Marie-Christine Etienne, E Teissier, I. Peyrottes, Mireille Francoual, Jean-Louis Formento, Gérard Milano
Publikováno v:
British Journal of Cancer
The long-term prognostic value of tumoural MDR1 and MRP, along with p53 and other classical parameters, was analysed on 85 node-positive breast cancer patients receiving anthracycline-based adjuvant therapy. All patients underwent tumour resection pl